p21(Cip-1/SDI-1/WAF-1) expression via the mitogen-activated protein kinase signaling pathway in insulin-induced chondrogenic differentiation of ATDC5 cells

Biochemical and Biophysical Research Communications
Masahiro NakajimaK Kawashima

Abstract

The embryonal carcinoma-derived cell line, ATDC5, differentiates into chondrocytes in response to insulin or insulin-like growth factor-I stimulation. In this study, we investigated the roles of mitogen-activated protein (MAP) kinases in insulin-induced chondrogenic differentiation of ATDC5 cells. Insulin-induced accumulation of glycosaminoglycan and expression of chondrogenic differentiation markers, type II collagen, type X collagen, and aggrecan mRNA were inhibited by the MEK1/2 inhibitor (U0126) and the p38 MAP kinase inhibitor (SB203580). Conversely, the JNK inhibitor (SP600125) enhanced the synthesis of glycosaminoglycan and expression of chondrogenic differentiation markers. Insulin-induced phosphorylation of ERK1/2 and JNK but not that of p38 MAP kinase. We have previously clarified that the induction of the cyclin-dependent kinase inhibitor, p21(Cip-1/SDI-1/WAF-1), is essential for chondrogenic differentiation of ATDC5 cells. To assess the relationship between the induction of p21 and MAP kinase activity, we investigated the effect of these inhibitors on insulin-induced p21 expression in ATDC5 cells. Insulin-induced accumulation of p21 mRNA and protein was inhibited by the addition of U0126 and SB203580. In contrast, S...Continue Reading

References

Jan 1, 1995·International Review of Cytology·R CanceddaP Castagnola
Feb 1, 1996·Current Opinion in Genetics & Development·J W Harper, S J Elledge
Dec 1, 1996·Current Biology : CB·G A Wallis
Apr 1, 1997·Current Opinion in Cell Biology·M J Robinson, M H Cobb
Jun 1, 1997·Histochemistry and Cell Biology·T AignerK von der Mark
Feb 11, 1998·Experimental Cell Research·B JohnstoneJ U Yoo
May 6, 1998·Matrix Biology : Journal of the International Society for Matrix Biology·V Lefebvre, B de Crombrugghe
Jan 30, 1999·Genes & Development·P ZhangS J Elledge
Mar 19, 1999·Molecular and Cellular Biology·H J Schaeffer, M J Weber
Oct 9, 1999·The Journal of Biological Chemistry·F BeierP LuValle
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·S MurakamiB de Crombrugghe
Jun 15, 2001·The Journal of Biological Chemistry·Y NegishiH Endo
Aug 28, 2002·Immunity·Michelle R TourignySelina Chen-Kiang

❮ Previous
Next ❯

Citations

Dec 2, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Manuela Wuelling, Andrea Vortkamp
Feb 22, 2012·The Journal of Biological Chemistry·Dongkyun KimEun-Jung Jin
Jun 10, 2010·American Journal of Physiology. Endocrinology and Metabolism·Tecla M TemuChanika Phornphutkul
Nov 8, 2014·Molecular Medicine Reports·Nobuaki ChinzeiMasahiro Kurosaka
Nov 14, 2006·Developmental Biology·Dmitry NurminskyMaria Nurminskaya
Oct 24, 2017·Journal of Cellular Physiology·Weifeng XuShanyong Zhang
Jun 12, 2008·Birth Defects Research. Part C, Embryo Today : Reviews·Brent E Bobick, William M Kulyk
Dec 5, 2009·Birth Defects Research. Part C, Embryo Today : Reviews·Brent E BobickRocky S Tuan
Mar 18, 2020·Scientific Reports·Rosie GriffithsSusan J Kimber
Apr 13, 2010·Molecular and Cellular Endocrinology·T Delessa ChallaE Monsonego Ornan
Nov 15, 2011·Biochemical and Biophysical Research Communications·Dongkyun KimEun-Jung Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.